Mark A. Hillman Holdings Activity

Hillman Value Fund Portfolio 13F

Hillman Value Fund has disclosed a total of 11 changes to the portfolio in the latest (2024 Q3) SEC report(s): increased the number of shares of 5, bought 1 totally new, decreased the number of shares of 3 and completely sold out 2 position(s).

What stocks is Mark A. Hillman buying now?

In the recent quarter Mark A. Hillman has bought 6 securities out of which top 5 purchases (by % change to portfolio) are (NUE) NUCOR CORP (new buy), (EL) ESTEE LAUDER COMPANIES-CL A (added shares +31.82%), (DIS) WALT DISNEY CO/THE (added shares +25%), (NKE) NIKE INC -CL B (added shares +19.84%) and (INTC) INTEL CORP (added shares +32.32%).

What does Mark A. Hillman invest in?

Mark A. Hillman's top 5 holdings (by % of portfolio) are (BMY) BRISTOL-MYERS SQUIBB CO (3.48%), (UMBXX) MONEY MARKET FIDUCIA (3.33%), (USB) US BANCORP (3.12%), (T) AT&T INC (2.99%) and (DD) DUPONT DE NEMOURS INC (2.96%).

In the latest report(s) the following change has been made to the top investments: (UMBXX) MONEY MARKET FIDUCIA (reduced shares -21.65%).

2023 Q1 (9 results)
UMBXX
+362.15%
+7,625,554
+3.77%
$1.00
-
4.81%
CMP
+42.31%
+44,000
+0.75%
$34.29
62.70% $12.79
2.51%
AMZN
+38.10%
+16,000
+0.82%
$103.29
123.79% $231.15
2.96%
WU
+25.85%
+84,000
+0.46%
$11.15
0.09% $11.14
2.25%
META
-22.97%
-8,200
-0.86%
$211.94
192.27% $619.44
2.88%
BA
-23.64%
-7,800
-0.82%
$212.43
18.55% $173.03
2.65%
BK
-23.78%
-33,388
-0.75%
$45.44
72.65% $78.45
2.40%
WBD
-33.05%
-178,300
-1.33%
$15.10
24.83% $11.35
2.70%
RTX
-100.00%
-55,000
-2.74%
$100.92
16.35% $117.42
0.00%
2022 Q4 (11 results)
DIS
buy
+60,000
+2.77%
$86.88
30.09% $113.02
2.77%
WBD
+50.43%
+180,866
+0.91%
$9.48
19.73% $11.35
2.72%
INTC
+15.91%
+23,000
+0.32%
$26.43
22.66% $20.44
2.35%
RTX
-15.38%
-10,000
-0.54%
$100.92
16.35% $117.42
0.00%
ZBH
-16.71%
-8,849
-0.60%
$127.50
15.25% $108.06
2.99%
T
-17.80%
-61,269
-0.60%
$18.41
24.01% $22.83
2.77%
CAG
-18.86%
-33,000
-0.68%
$38.70
27.96% $27.88
2.92%
DD
-19.72%
-18,664
-0.68%
$68.63
16.76% $80.13
2.77%
ASML
-24.13%
-2,700
-0.78%
$546.40
34.55% $735.19
2.46%
UMBXX
-70.35%
-4,996,194
-2.65%
$1.00
-
1.12%
MRK
-100.00%
-60,169
-2.75%
$86.12
16.19% $100.06
0.00%
2022 Q3 (13 results)
GSK
buy
+172,865
+2.83%
$29.43
16.31% $34.23
2.83%
TSM
buy
+67,729
+2.58%
$68.56
192.68% $200.66
2.58%
UMBXX
+125.51%
+3,952,551
+2.20%
$1.00
-
3.95%
INTC
+1.27%
+1,810
+0.03%
$25.77
20.68% $20.44
2.07%
EPD
-11.54%
-30,000
-0.40%
$23.78
31.58% $31.29
3.04%
LRCX
-12.50%
-1,800
-0.37%
$366.00
78.74% $77.81
2.56%
CAG
-12.50%
-25,000
-0.45%
$32.63
14.56% $27.88
3.17%
KHC
-22.84%
-45,000
-0.83%
$33.35
6.30% $31.25
2.82%
K
-29.09%
-32,000
-1.24%
$69.66
15.69% $80.59
3.02%
MRK
-33.15%
-29,831
-1.43%
$86.12
16.19% $100.06
0.00%
BIIB
-37.25%
-10,839
-1.61%
$267.00
43.58% $150.64
2.71%
PAA
-100.00%
-610,000
-3.33%
$9.82
77.60% $17.44
0.00%
GSK
-100.00%
-128,000
-3.87%
$54.41
37.09% $34.23
0.00%
2022 Q2 (17 results)
LRCX
buy
+14,400
+2.94%
$426.15
81.74% $77.81
2.94%
WBD
buy
+358,640
+2.31%
$13.42
15.42% $11.35
2.31%
T
+49.68%
+114,269
+1.15%
$20.96
8.92% $22.83
3.46%
BK
+27.63%
+30,388
+0.61%
$41.71
88.08% $78.45
2.81%
CRM
+24.89%
+7,615
+0.60%
$165.04
112.66% $350.97
3.02%
MSFT
+19.72%
+3,846
+0.47%
$256.83
76.95% $454.46
2.87%
WFC
+18.12%
+22,655
+0.43%
$39.17
80.78% $70.81
2.77%
INTC
+16.85%
+20,595
+0.37%
$37.41
45.36% $20.44
2.56%
META
+15.16%
+4,700
+0.36%
$161.25
284.15% $619.44
2.76%
ZBH
+12.66%
+5,949
+0.30%
$105.06
2.86% $108.06
2.67%
ASML
+11.88%
+1,188
+0.27%
$475.88
54.49% $735.19
2.55%
DD
+7.57%
+6,664
+0.18%
$55.58
44.17% $80.13
2.52%
UMBXX
-70.07%
-7,373,901
-3.54%
$1.00
-
1.51%
MMP
-100.00%
-141,000
-3.32%
$49.07
40.62% $69.00
0.00%
BMY
-100.00%
-93,000
-3.26%
$73.03
21.06% $57.65
0.00%
DISCA
-100.00%
-223,000
-2.66%
$24.92
1.97% $24.43
0.00%
ZIMV
-100.00%
-4,700
-0.05%
$22.84
38.92% $13.95
0.00%
50 of 271

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.